Register for our free email digests:
EU Regulation Recap
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
In what way are the EU requirements for clinical evaluations and clinical investigations for medical devices changing under the Medical Devices Regulation compared with the current medical device directives? Here’s a look at Chapter VI of the impending MDR.
What will happen when there is a dispute over which risk class a product falls into under the future Medical Device and IVD Regulations? How does the scrutiny process differ for medical devices and IVDs? Here we detail chapter V of the future regulations, which addresses these and other classification and conformity-assessment issues.
What procedures will manufacturers need to follow to comply with the future medical device and IVD regulations, and when will a notified body need to be involved? A look at these issues as addressed in the fifth chapter of the pending regulatory documents.
How can you be sure that your notified body is operating fairly and to a high standard? How long can your products remain on the market if your notified body’s operations are suspended or simply cease? Chapter IV of the forthcoming Medical Device and IVD Regulations details requirements for notified bodies as well as the process for their designation and monitoring.
These reference articles from Medtech Insight will help get readers back on track as the EU returns from its traditional summer break.
EU Regulation Recap: Traceability and UDI, Registration, Eudamed, And More From MDR/IVDR Chapter III
The third chapters of the Medical Devices Regulation and IVD Regulation are substantially similar in addressing UDI, and also in dealing with subjects surrounding device identification and traceability; registration of devices and of economic operators; summary of safety and clinical performance; and the European databank on medical devices (Eudamed). This is the latest in our series of articles delving into the MDR and IVDR, chapter-by-chapter.
EU Regulation Recap: IVDR Chapter II – Economic Operators, Reprocessing, CE-Marking And Free Movement
In the third article of a series that takes a deep dive into the EU's forthcoming Medical Device and IVD Regulations, Medtech Insight focuses on the second chapter of the IVD regulatory text. This chapter looks at the making available and putting into services of devices, obligations of economic operators, reprocessing, CE-marking and free movement.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.